Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Priming studies with rocuronium and vecuronium

I Redai1, S A Feldman

  • 1Magill Department of Anaesthetics, Chelsea and Westminster Hospital, London, UK.

European Journal of Anaesthesiology. Supplement
|September 1, 1995
PubMed
Summary

Vecuronium effectively primes rocuronium, reducing its onset time by 33%. Both vecuronium and rocuronium, when used as priming agents, shorten the onset of vecuronium neuromuscular blockade.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-viral chimeric antigen receptor (CAR) T cells going viral.

Immuno-oncology technology·2023
Same author

Transnasal topical sphenopalatine ganglion block to treat tension headache in a pregnant patient.

International journal of obstetric anesthesia·2014
Same author

Oxygenation of cats by hydrogen peroxide during temporary ventilatory arrest.

British medical journal·2010
Same author

Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex.

Archives of virology·2002
Same author

The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate.

Journal of virology·2000
Same author

CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness.

American journal of respiratory and critical care medicine·2000

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Neuromuscular blocking agents are essential in anesthesia.
  • Optimizing the onset of neuromuscular blockade is clinically significant.

Purpose of the Study:

  • To evaluate rocuronium and vecuronium as priming agents for subsequent neuromuscular blockade.
  • To determine the efficacy of priming with these agents on onset time.

Main Methods:

  • Investigated rocuronium and vecuronium priming before rocuronium or vecuronium administration.
  • Measured the onset time of neuromuscular blockade after priming.

Main Results:

  • Rocuronium was ineffective as a priming agent for rocuronium.
  • Vecuronium priming reduced rocuronium onset time by approximately 33%.
  • Both rocuronium and vecuronium priming reduced the onset time of vecuronium blockade.

Conclusions:

  • Vecuronium is an effective priming agent for rocuronium.
  • Priming strategies can significantly reduce neuromuscular blockade onset time.
  • Further research into optimizing neuromuscular blockade induction is warranted.

Related Experiment Videos